Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy
独家：加州大学伯克利分校初创公司押注“跳跃基因”用于胰高血糖素样肽-1基因疗法

The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drugs quit the medicines within a year.
新一代减重药物在维持体重下降方面效果空前——前提是患者持续用药。然而，多项研究表明，大多数开始使用胰高血糖素样肽-1药物的人会在一年内停药。